Breaking News Instant updates and real-time market news.

BBBY

Bed Bath & Beyond

$45.56

-0.64 (-1.39%)

15:20
12/22/16
12/22
15:20
12/22/16
15:20

Bed, Bath and Beyond puts with heavy trading as shares falter

Bed, Bath and Beyond puts with heavy trading as shares falter. The stock is down $4.44 to $41.12 on earnings and 3.2K Dec 23rd 46 puts have changed hands. Jan 45, Dec 23rd 45 puts, and Dec 23rd 44 puts are next most active. In fact, the thirteen most active options in Bed, Bath and Beyond are puts and put volume trounces call activity 3:1. 22K puts and 7.2K calls so far.

BBBY Bed Bath & Beyond
$45.56

-0.64 (-1.39%)

12/20/16
CLVD
12/20/16
DOWNGRADE
CLVD
Underperform
Bed Bath & Beyond downgraded to Underperform from Neutral at Cleveland Research
Cleveland Research analyst Daryl Boehringer downgraded Bed Bath & Beyond to Underperform following checks that indicate comp trends remain "uninspiring" given declining traffic, online migration, lack of market share gains. The analyst sees Q3 comps flat to slightly below consensus of +.4% and continues to see comp risk over the near-term and said it appears traffic has slowed noticeably over the last six weeks.
12/20/16
12/20/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Amgen (AMGN) downgraded to Neutral from Outperform at Credit Suisse with analyst Alethia Young saying she has a lower conviction in the base business and sees limited upside to positive PCSK9 outcomes in the first quarter of 2017 given high expectations. 2. Bed Bath & Beyond (BBBY) downgraded to Underperform from Neutral at Cleveland Research with analyst Daryl Boehringer citing checks that indicate comp trends remain "uninspiring" given declining traffic, online migration, lack of market share gains. 3. Sibanye Gold (SBGL) downgraded to Sell from Hold at Deutsche Bank with analyst Patrick Mann saying he expects a "challenging" 2017 for the company as EBITDA declines. 4. Cempra (CEMP) downgraded to Sell from Buy at SunTrust with analyst Edward Nash saying says he expects the FDA to provide complete response letters for the company's solithromycin treatment due to manufacturing issues. 5. Acuity Brands (AYI) downgraded to Neutral from Outperform at Baird with analyst Timothy Wojs saying he believes a near-term demand lull could keep the stock range bound over the next couple of quarters, leaving a thin margin for error. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/22/16
RAJA
12/22/16
DOWNGRADE
RAJA
Market Perform
Bed Bath & Beyond downgraded to Market Perform from Strong Buy at Raymond James
Raymond James analyst Budd Bugatch downgraded Bed Bath & Beyond to Market Perform from Strong Buy following the Q3 sales and earnings miss. The analyst said Bed Bath still has a long runway ahead before it realizes benefits from technology investments, membership program, and recent investments in One Kings Lane and PMall.com. Bugatch recommends moving to the sidelines until gross margins and operating expenses stabilize and the benefits of incremental investments are quantifiable.
12/22/16
12/22/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Hold from Buy at SunTrust with analyst William Chappell, Jr. predicting that, "foreign exchange headwinds and waning investor appetites for higher yields" will cause the stock "to stay in a trading range in coming quarters." 2. Praxair (PX) downgraded to Underperform from Outperform at CLSA. 3. Bed Bath & Beyond (BBBY) downgraded to Market Perform from Strong Buy at Raymond James with analyst Budd Bugatch saying Bed Bath still has a long runway ahead before it realizes benefits from technology investments, membership program, and recent investments in One Kings Lane and PMall.com. 4. Finish Line (FINL) downgraded to Neutral from Buy at Monness Crespi, to Neutral from Outperform at Wedbush, to Hold from Buy at Canaccord, to Neutral from Buy at B. Riley, and to Neutral from Buy at BofA/Merrill. 5. Red Hat (RHT) downgraded to Hold from Buy at Stifel and to Market Perform from Outperform at BMO Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SLV

iShares Silver Trust

$16.17

0.16 (1.00%)

06:22
11/24/17
11/24
06:22
11/24/17
06:22
Technical Analysis
iShares Silver Trust: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USLV

VelocityShares 3x Long Silver ETN

$12.17

0.39 (3.31%)

06:21
11/24/17
11/24
06:21
11/24/17
06:21
Technical Analysis
VelocityShares 3x Long Silver ETN: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYR

DJ US Real Estate Index Fund

$82.33

-0.23 (-0.28%)

06:20
11/24/17
11/24
06:20
11/24/17
06:20
Technical Analysis
DJ US Real Estate Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBB

iShares Nasdaq Biotechnology Index

$312.52

1.81 (0.58%)

06:19
11/24/17
11/24
06:19
11/24/17
06:19
Technical Analysis
iShares Nasdaq Biotechnology Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LABD

Daily S&P Biotech Bear 3x Shares

$5.34

-0.09 (-1.66%)

06:19
11/24/17
11/24
06:19
11/24/17
06:19
Technical Analysis
Daily S&P Biotech Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAYRY

Bayer

$32.05

-0.15 (-0.47%)

, NKTR

Nektar

$49.75

-0.23 (-0.46%)

06:19
11/24/17
11/24
06:19
11/24/17
06:19
Hot Stocks
Bayer announces INHALE Phase III clinical study did not meet primary endpoint »

Bayer (BAYRY) announced…

BAYRY

Bayer

$32.05

-0.15 (-0.47%)

NKTR

Nektar

$49.75

-0.23 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWH

MSCI Hong Kong Index

$26.02

0.02 (0.08%)

06:19
11/24/17
11/24
06:19
11/24/17
06:19
Technical Analysis
MSCI Hong Kong Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWG

iShares MSCI Germany

$32.82

-0.22 (-0.67%)

06:18
11/24/17
11/24
06:18
11/24/17
06:18
Technical Analysis
iShares MSCI Germany: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCMGY

Newcrest Mining

$18.13

0.2 (1.12%)

06:18
11/24/17
11/24
06:18
11/24/17
06:18
Downgrade
Newcrest Mining rating change  »

Newcrest Mining…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IJR

iShares Core S&P Small Cap ETF

$76.06

-0.16 (-0.21%)

06:16
11/24/17
11/24
06:16
11/24/17
06:16
Technical Analysis
iShares Core S&P Small Cap ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

$47.81

0.12 (0.25%)

06:16
11/24/17
11/24
06:16
11/24/17
06:16
Technical Analysis
MSCI Emerging Markets Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWW

iShares MSCI Mexico

$51.43

0.4 (0.78%)

06:14
11/24/17
11/24
06:14
11/24/17
06:14
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPYYY

Centrica

$8.66

0.18 (2.12%)

06:14
11/24/17
11/24
06:14
11/24/17
06:14
Upgrade
Centrica rating change  »

Centrica upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$50.43

0.39 (0.78%)

, CBS

CBS

$56.24

-0.5 (-0.88%)

06:14
11/24/17
11/24
06:14
11/24/17
06:14
Hot Stocks
Dish reaches multi-year carriage agreement with CBS, terms not disclosed »

DISH Network (DISH) has…

DISH

Dish

$50.43

0.39 (0.78%)

CBS

CBS

$56.24

-0.5 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUP

PowerShares DB US Dollar Index Up

$24.24

-0.19 (-0.78%)

06:14
11/24/17
11/24
06:14
11/24/17
06:14
Technical Analysis
PowerShares DB US Dollar Index Up: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDN

PowerShares DB US Dollar Index Down

$22.23

0.1881 (0.85%)

06:13
11/24/17
11/24
06:13
11/24/17
06:13
Technical Analysis
PowerShares DB US Dollar Index Down: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$13.48

0.15 (1.13%)

06:10
11/24/17
11/24
06:10
11/24/17
06:10
Periodicals
Teva to slash up to 25% of Israeli workforce, Bloomberg reports »

Teva intends to cut as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BASFY

BASF

$27.39

-0.13 (-0.47%)

04:55
11/24/17
11/24
04:55
11/24/17
04:55
Conference/Events
BASF management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Nov

04:55
11/24/17
11/24
04:55
11/24/17
04:55
General news
PMI Composite Flash Manufacturing â€' Level to be reported at 09:45 »

November PMI Composite…

RBS

RBS

$7.30

-0.04 (-0.54%)

04:55
11/24/17
11/24
04:55
11/24/17
04:55
Conference/Events
RBS management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Nov

04:55
11/24/17
11/24
04:55
11/24/17
04:55
General news
Breaking General news story  »

Week of 11/22 Fed Balance…

04:55
11/24/17
11/24
04:55
11/24/17
04:55
General news
Breaking General news story  »

Week of 11/24…

04:55
11/24/17
11/24
04:55
11/24/17
04:55
General news
Breaking General news story  »

Week of 11/13 Money…

04:55
11/24/17
11/24
04:55
11/24/17
04:55
Conference/Events
RBC Capital to hold field trip »

European Utilities Field…

04:55
11/24/17
11/24
04:55
11/24/17
04:55
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

November PMI Composite…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.